Moderna mRNA Melanoma Vaccine Plus Keytruda Shows Phase 3 Benefit
10h
Breaking
2
On Wednesday, August 19, 2026, CBS reported that a Phase 3 trial found Moderna's personalized mRNA melanoma vaccine given with Merck's Keytruda kept patients cancer-free longer than Keytruda alone. CBS News
